Hepatitis A virus epidemiology in Turkey as universal childhood vaccination begins: seroprevalence and endemicity by region
Demiray T, Köroğlu M, Jacobsen KH, Özbek A, Terzi HA, Altındiş M. Hepatitis A virus epidemiology in Turkey as universal childhood vaccination begins: seroprevalence and endemicity by region. Turk J Pediatr 2016; 58: 480-491.This paper presents the results of a comprehensive examination of current distribution of Hepatitis A virus (HAV) seroprevalence and endemicity in Turkey and the possible links between HAV endemicity and socioeconomic development. We performed a systematic search in online resources published between January 2000 and August 2015. The 22 provinces were able to be assigned a hepatitis A endemicity level based on this systematic review. The incidence rates for symptomatic hepatitis A infection are higher in the eastern part of Turkey than in the western and central region. These differences in socioeconomic indicators by region suggest the likelihood of lower seroprevalence rates in the western parts of the country and higher rates in the eastern region. Turkey's current policy of recommending hepatitis A immunization for all children without contraindications is an appropriate one and is likely to remain the best option for at least the next decade or two
___
1. Jacobsen KH, Wiersma ST. Hepatitis A virus seroprevalence by age and world region, 1990 and 2005. Vaccine 2010; 28: 6653-6657.2. Jacobsen KH, Koopman JS. Declining hepatitis A seroprevalence: a global review and analysis. Epidemiol Infect 2004; 132: 1005-1022.
3. Jacobsen KH, Koopman JS. The effects of socioeconomic development on worldwide hepatitis A virus seroprevalence patterns. Int J Epidemiol 2005; 34: 600-609.
4. WHO position paper on hepatitis A vaccines, June 2012. Wkly Epidemiol Rec 2012; 87: 261-276.
5. Mohd Hanafiah K, Jacobsen KH, Wiersma ST. Challenges to mapping the health risk of hepatitis A virus infection. Int J Health Geogr 2011; 10: 57.
6. Moher D, Shamseer L, Clarke M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev 2015; 4: 1.
7. Avci HH, Selcuk EB, Pehlivan E, Hulya E. Implementation of a new vaccine in Turkey: hepatitis A. Eurasian J Fam Med 2014; 3: 9-14.
8. Koroglu M, Demiray T, Terzi HA, Altindis M. Seroprevalence of hepatitis A among different age groups in Sakarya and review of the literature. Viral Hepat J 2014; 20: 110-114.
9. Parlak M, Guven A, Erdin BN, Bayram Y. Seroprevalence of hepatitis-A virus among child and adult age groups admitted to a training and research hospital. Viral Hepat J 2015; 21: 20-22.
10. Nalbantoglu B, Donma M, Ozdilek B, Karasu E, Nalbantoglu A. Shifting epidemiology of hepatitis A infection and vaccination status of children aged 6 months-12 years: time for mass vaccination. Iran J Pediatr 2013; 23: 276-280.
11. Itani T, Jacobsen KH, Nguyen T, Wiktor SZ. A new method for imputing country-level estimates of hepatitis A virus endemicity levels in the Eastern Mediterranean region. Vaccine 2014; 32: 6067-6074.
12. Turkish Statistical Institute. Municipal Water Statistics Database [Belediye Su İstatistikleri Veritabanı] 2012. http://www.turkstat.gov.tr/PreTabloArama. do?metod=search&araType=vt
13. Turkish Statistical Institute. Municipal Wastewater Statistics Database [Belediye Atıksu İstatistikleri Veritabanı] 2012. http://www.turkstat.gov.tr/ PreTabloArama.do?metod=search&araType=vt
14. Turkish Statistical Institute. Selected Regional Statistics [Seçilmiş Bölge İstatistikleri] 2013. Available from: http://www.tuik.gov.tr/ilGostergeleri/index.html.
15. Taskaya S, Sahin B, Demirkiran M, Balcik P. The Relationship between Human Resources for Health and Development Levels of Provinces. J of Econ, Finance and Account 2015; 2: 672-679.
16. Arabaci F, Oldacay M. The seroprevalance of hepatitis A in different age groups and hepatitis A incidence in acute hepatitis cases in the Canakkale province. J Pediatr Infect 2009; 3: 58-61.
17. Kaya AD, Ozturk CE, Yavuz T, Ozaydin C, Bahcebasi T. Changing patterns of hepatitis A and E sero-prevalences in children after the 1999 earthquakes in Duzce, Turkey. J Paediatr Child Health 2008; 44: 205-207.
18. Erdogan M, Otkun M, Tatman-Otkun M, Akata F, Ture M. The epidemiology of hepatitis A virus infection in children, in Edirne, Turkey. Eur J Epidemiol 2004; 19: 267-273.
19. Ceran N, Yuksel Kocdogan F, Mert D, et al. Hepatitis A seroprevalence in children and young adults in Istanbul, Turkey: seroprevalence change and associated factors. J Viral Hepat 2012; 19: 72-76.
20. Iraz M, Gultepe B, Doymaz MZ. Seroprevalance of hepatitis A in the adult age groups. Abant Med J 2015; 4: 54-58.
21. Alici O, Agalar C, Yazicilar HA. Hepatitis A seroprevalence in patients who admitted to training and research hospital in Istanbul. Viral Hepat J 2013; 19: 100-114.
22. Topal E, Hatipoglu N, Turel O, et al. Seroprevalence of hepatitis A and hepatitis A vaccination rate in preschool age in Istanbul urban. J Pediatr Infect 2011; 5: 12-15.
23. Kocdogan FY. Relationship of socio-economic factors with hepatitis A virus from different age groups in Istanbul [İstanbul'da Farklı Yas Gruplarında Hepatit A Prevalansı ve Sosyo-Ekonomik Faktörlerle İlişkisi] [master's thesis]. Istanbul: Haydarpaşa Numune Education and Training Hospital; 2006.
24. Soysal A, Gokce I, Pehlivan T, Bakir M. Interchangeability of a hepatitis A vaccine second dose: Avaxim 80 following a first dose of Vaqta 25 or Havrix 720 in children in Turkey. Eur J Pediatr 2007; 166: 533-539.
25. Guven F, Erkum AY, Erkum T, Say A. Seroprevalence of hepatitis A in children age 0-15. Zeynep Kamil Tıp Bulteni 2004; 35: 41-44.
26. Kose S, Mandiracioglu A, Cavdar G, et al. The seroprevalence of hepatitis A in adults in Izmir: prior to introducing vaccine into routine vaccination program. Nobel Med 2013; 9: 49-53.
27. Kurugol Z, Aslan A, Turkoglu E, Koturoglu G. Changing epidemiology of hepatitis A infection in Izmir, Turkey. Vaccine 2011; 29: 6259-6261.
28. Ozkinay F, Kurugol Z, Koturoglu G, et al. The epidemiology of hepatitis A infection in the population of Bornova, Izmir, Turkey. Ege Tip Dergisi 2007; 46: 1-6.
29. Egemen A, Yilmaz O, Akil I, Altuglu I. Evaluation of association between hepatitis A and Helicobacter pylori infections and routes of transmission. Turk J Pediatr 2006; 48: 135-139.
30. Bayram ED, Ergin OY, Tosun S. Evaluation of the changes at the ages of contact with hepatitis A virus. Proceedings of the 12th National Congress of Viral Hepatitis; Antalya, 2014: 114.
31. Halicioglu O, Akman SA, Tatar B, Atesli R, Kose S. Hepatitis A seroprevalence in children and adolescents aged 1-18 years among a low socioeconomic population in Izmir, Turkey. Travel Med Infect Dis 2012; 10: 43- 47.
32. Tosun S, Ertan P, Kasirga E, Atman U. Changes in seroprevalence of hepatitis A in children and adolescents in Manisa, Turkey. Pediatr Int 2004; 46 :669-672.
33. Tosun S, Ayaz H, Deveci S, Aksu S. Evaluation of the contact status of the children and adults with Hepatitis A virus. Proceedings of the 10th National Congress of Viral Hepatitis; Antalya, 2010: 121.
34. Ince OT, Yalcin SS, Yurdakok K, Ozmert EN. Hepatitis A seroprevalence among infants aged 12 months in Ankara. Turk J Pediatr 2011; 53: 114-116.
35. Karakaş A, Coşkun O, Mert G, Gul Hanefi C, Avci IY, Eyigun CP. What has changed in Hepatitis A seroprevalence in seven years. Proceedings of the 12th National Congress of Viral Hepatitis; Antalya, 2012: 51.
36. Dede A, Caliskan E, Guven GB, Cizmeci Z. Hepatitis A seropositivity in outpatients at Kecioren Teaching and Research Hospital Viral Hepat J 2013; 19: 163- 164.
37. Turker K, Balci E, Bati S, Hascuhadar M, Savas E. The changing epidemiology of hepatitis A infection in Turkey. Turk Mikrobiyol Cem Derg 2011; 41: 143-148.
38. Genc G, Yilmaz G, Karacan C, Atay N, Yoney A. Hepattis A seroprevalence among 2-6 year-old children of low socioeconomic class families. Erciyes Med J 2006; 28: 188-191.
39. Cesur S, Akin K, Dogaroglu İ, Birengel S, Balik İ. Hepatitis A and hepatitis E seroprevalence in adults of Ankara area. Mikrobiyol Bul 2002; 36: 79-83.
40. Sac R, Bostanc I, Dallar Y, Cihan G, Atli O. Hepatitis A seroprevalence and demographics in Turkish children in Ankara. Pediatr Int 2009; 51: 5-8.
41. Coskun O, Erdem H, Gul HC, Eyigun CP. Changes in hepatitis A prevalence rates between 1998 and 2007 in Eskisehir, Turkey. Int J Infect Dis 2008; 12: e141.
42. Alhan E, Kozanoglu B, Tumgor G, Celik U, Yaman A, Bozdemir N. Epidemiological shift of hepatitis A in central Adana, Turkey. Turk J Gastroenterol 2014; 25: S6-S8.
43. Ocak S, Kaya H, Cetin M, Inandi T. Seropositivity of hepatitis A and B according to age and sex in preoperative patients in Antakya.Viral Hepat J 2005; 10: 169-175.
44. Turhan E, Cetin M. The seroprevalence of viral hepatitis A in patients who had consulted at Mustafa Kemal University of Medicine Faculty. Viral Hepat J 2007; 12: 30-34.
45. Kaygusuz S, Kilic D, Ayaslioglu E, Ozluk O, Cerit L, Yildirim A. Seroprevalence of anti-HAV, HBsAg, anti-HBs and anti-HCV according to age and sex in Kirikkale. Viral Hepat J 2003; 8: 160-165.
46. Atabek ME, Findik D, Gulyuz A, Erkul I. Prevalence of anti-HAV and anti-HEV antibodies in Konya, Turkey. Health Policy 2004; 67: 265-269.
47. Kalem F, Erayman B, Yuksekkaya Ş, Kara F. The seroepidemiology of hepatitis A in Konya. Viral Hepat J 2013; 19: 19-22.
48. Energin VM, Elmas S, Sert A. Frequency of hepatitis B in children applying to outpatient clinics of pediatrics in Meram Medical Faculty of Selcuk University. Selcuk Tıp Derg 2007; 23: 161-166.
49. Cetinkol Y, Yildirim AA. The evaluation of the HBsAg, anti-HBs, anti-HCV and anti-HAV IgG results in medical career college students. Viral Hepat J 2012; 18: 23-25.
50. Cetinkol Y, Altuncekic Yildirim A. The seroprevalence of viral hepatitis A in patients who had been consulted at Unye State Hospital. Kocatepe Med J 2011; 12: 18-22.
51. Demirpence O, Tezcan SI, Degirmen E, Mert D, Gumuş A, Celen MK. Seroprevalence of HAV, HBV, HVC and HIV in people admitted to Batman State Hospital. Viral Hepat J 2012; 18: 6-10.
52. Deveci U, Ustun C, Hamanca O. Seroprevalence of hepatitis A virus among children aged 1-16 years in Eastern Anatolia, Turkey. Afr Journal Microbiol Res 2011; 5: 5969-5971.
53. Vancelik S, Guraksin A, Alp H. Hepatitis A seroepidemiology in Eastern Turkey. East Afr Med J 2006; 83: 86-90.
54. Altinkaynak S, Selimoglu MA, Ertekin V, Kilicaslan B. Epidemiological factors affecting hepatitis A seroprevalence in childhood in a developing country. Eurasian J Med 2008; 40: 25-28.
55. Karsligil T, Eksi F, Balci İ, Belgin R. The seroprevalence of hepatitis A and E in our region. Viral Hepat J 2003; 8: 155-159.
56. Aslan S, Degirmenci S, Citak C, Yis R. Evaluation of hepatitis A indicators in Gaziantep Children's Hospital in two years-period. Proceedings of the 10th National Congress of Viral Hepatitis; Antalya, 2010: 117.
57. Tekay F. Hepatitis A frequency in children of between 0-14 age group who had consulted at Hakkari Province Hospital. Dicle Tip Dergisi 2006; 33: 245-247.
58. Kaya D, Guler E, Ekerbicer HC, et al. Hepatitis A seroprevalence and its relationship with environmental factors in children of different age groups in Kahramanmaras, Eastern Mediterranean region of Turkey. J Viral Hepat 2007; 14: 830-834.
59. Ozen M, Yologlu S, Isik Y, Tekerekoglu MS. Anti-HAV IgG seropositivity in children aged between 2-16 years who were admitted to Turgut Ozal Medical Center. Turk Pediatri Arsivi 2006; 41: 36-40.
60. Erturk A, Copur Cicek A, Cure E, Akdogan RA, Ozturk C. Seroprevalence of hepatitis A in Rize Province and different adult age groups. Viral Hepat J 2013; 19: 85-88.
61. Karaman S, Karaman K, Kizilyildiz BS, et al. Seroprevalence of hepatitis A and associated factors among 1-15 year old children in eastern Turkey. Int J Clin Exp Med 2015; 8: 19394-19399.
62. Okur M, Erbey F, Acar MN, Guven A, Kaya A. The seropositivity of hepatitis A in children between 0-18 years in the Van province and around. Duzce Med J 2011; 13: 6-9.
63. Arabaci F, Demirli H. The seroprevalence of hepatitis A and B in children 6-10 years of age Turk J Infect 2005; 19: 457-460.
64. Turkish Statistical Institute. Population of provinces by years, 2007-2014 [Yıllara göre il nüfusları, 2007-2014] 2014. http://www.tuik.gov.tr/PreTablo.do?alt_id=1059
65. Ceyhan M, Yildirim I, Kurt N, et al. Differences in hepatitis A seroprevalence among geographical regions in Turkey: a need for regional vaccination recommendations. J Viral Hepat 2008; 15: S69-S72.
66. Ximenes RA, Martelli CM, Amaku M, et al. Modelling the force of infection for hepatitis A in an urban population-based survey: a comparison of transmission patterns in Brazilian macro-regions. PLos One 2014; 9: e94622.
67. Lazcano-Ponce E, Conde-Gonzalez C, Rojas R, DeAntonio R, Romano-Mazzotti L, Cervantes Y, Ortega-Barria E. Seroprevalence of hepatitis A virus in a cross-sectional study in Mexico: implications for hepatitis A vaccination. Hum Vaccin Immunother 2013; 9: 375-381.
68. Ansaldi F, Bruzzone B, Rota MC, Bella A, Ciofi degli Atti M, Durando P, et al. Hepatitis A incidence and hospital-based seroprevalence in Italy: a nation-wide study. Eur J Epidemiol 2008; 23: 45-53.
69. Mistik R. Epidemiology of the hepatitis A virus infections [Hepatit A Virus Enfeksiyonunun Epidemiyolojisi]. In: Tabak F, Tosun S, editors. Viral Hepatitis [Viral Hepatit], 1st ed. Istanbul: Istanbul Tıp Kitabevi; 2013: 15-23.
70. Yoldas O, Bulut A, Altindis M. The Current Approach of Hepatitis A Infections. Viral Hepat J 2012; 18: 81- 86.
- ISSN: 0041-4301
- Yayın Aralığı: Yılda 6 Sayı
- Başlangıç: 1958
- Yayıncı: Hacettepe Üniversitesi Çocuk Sağlığı Enstitüsü Müdürlüğü
Sayıdaki Diğer Makaleler
Coexistence of early onset sarcoidosis and partial interferon-? receptor 1 deficiency
Nuray AKTAY-AYAZ, Gonca KESKİNDEMİRCİ, Aysel KIYAK, Nevin HATİPOĞLU, Mustafa ÇAKAN, Çiğdem AYDOĞMUŞ, Gönü AYDOĞAN, Hilal AKI
Peutz-Jeghers syndrome: an unusual cause of recurrent intussusception in a 7-year-old boy
Ahmet ATICI, Sinan KILIÇ, Özlem SOYKÖSE-AÇIKALIN
Betül ERSOY, Mine ÖZKOL, Seniha KİREMİTCİ, Ahmet ERGİN, Bayram ÖZHAN
Gonadoblastoma in a patient with 46, XY complete gonadal dysgenesis
Ayşe KARAMAN, Semra ÇETİNKAYA, Erdal KURNAZ, Sema APAYDIN³, Melikşah KESKİN, Şenay SAVAŞ-ERDEVE, Zehra AYCAN¹
Bone marrow aspiration complications: Iliopsoas abscess and sacroiliac osteomyelitis
Tuğçe TURAL-KARA, Fatoş YALÇINKAYA, Suat FİTÖZ, Halil ÖZDEMİR, Ergin ÇİFTÇİ
Corynebacterium propinquum bronchopneumonia in a child with ataxia telangiectasia
Gülşah MALKOÇOĞLU, Haşim GENCER, AYŞENUR KAYA, NAZAN DALGIÇ, Mehmet Emin BULUT, Elif AKTAŞ
Tayfur DEMİRAY, MEHMET KÖROĞLU, Kathryn H JACOBSEN, Ahmet ÖZBEK, Hüseyin A. TERZİ, Mustafa ALTINDİŞ
Seizures and diagnostic difficulties in hyperinsulinism- hyperammonemia syndrome
Yasemin ALANAY, Sibel AKA, Serap SEMİZ, Kara E. BOODHANSİNGH, Charles A. STANLEY
Cardiac nodal and cardiac autonomic functions in children with vasovagal syncope
İbrahim ECE, Serkan ÇAY, Serhat KOCA, Denizhan BAĞRUL, Feyza A. PAÇ
Ufuk ATEŞ, Aydın YAĞMURLU, Gülnur GÖLLÜ, Onur TELLİ, Banu BİLEZİKÇİ, Banu YAĞMURLU, Rahşan Vargun YILDIZ, Bilgehan YALÇIN, Ergun ERGUN